Federal Supply Schedule V797P5950X

The Department of Veterans Affairs (VA) National Acquisition Center awarded a single-award Indefinite Delivery Contract (IDC) to The Harvard Drug Group, L.L.C., a subsidiary of Cardinal Health, Inc., for the supply of Bupropion Hydrochloride (HCL) Tablets in 100mg and 75mg dosages. The contract, valued at $2,936,792.25, has a base period of performance from March 1, 2025, to February 28, 2026, with four one-year option periods. The contracted items will be distributed through the VA's and...

This federal contract IDV award was issued by the Centers for Disease Control and Prevention (CDC) to procure pediatric vaccines for the Vaccines for Children (VFC) program. The 5-year, $1.35 billion multiple award contract aims to purchase standard commercial pediatric vaccines to support immunization efforts for eligible children, including those who are Medicaid-eligible, uninsured, American Indian/Alaska Native, or have insurance that does not cover vaccines. The prime contractor,...

The federal contract IDV award is an Indefinite Delivery Contract (IDC) valued at $9,999,999,999 awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp. The contract provides a comprehensive range of pharmaceutical and medical supplies to support military healthcare programs globally. The contract covers an extensive array of medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits...

The Defense Logistics Agency awarded an indefinite-delivery/indefinite-quantity contract to DMS Pharmaceutical Group Inc. to supply various pharmaceutical products and medical supplies in support of Department of Defense programs. Task orders issued against the contract procure medications, vaccines, and contraceptive implants for delivery to locations in Park Ridge, Illinois, with performance periods ranging from one day to several months. Notable orders include delivery of NUCALA...

This Federal Supply Schedule (FSS) contract was awarded by the Veterans Integrated Service Network 12, a civilian federal agency, to GC Biopharma USA, Inc. The contract has a ceiling value of $25,000.00 and a period of performance through January 14, 2025. The FSS contract is for the procurement of drugs, pharmaceuticals, and hematology related products under Schedule 65 IB. Additionally, a Blanket Purchase Agreement (BPA) was awarded under this FSS contract with a ceiling value of...

This Federal Supply Schedule (FSS) contract was awarded by the Department of Veterans Affairs (VA) to NS Pharma, Inc., a foreign-owned for-profit manufacturer of pharmaceutical and hematology-related products. The contract, with a ceiling value of $225,000, has an ultimate completion date of March 14, 2026 and was originally awarded on March 15, 2021. The scope of the contract includes the provision of "Drugs, Pharmaceuticals, & Hematology Related Products" under the GSA Schedule...

This Federal Supply Schedule (FSS) contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to Pierre Fabre Pharmaceuticals, Inc., a for-profit manufacturer. The contract has a ceiling value of $1,210,900.00 and a period of performance through September 26, 2029. The contract is for 65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, which indicates that the scope covers a wide range of pharmaceutical and hematology-related products....

This Federal Supply Schedule (FSS) contract, awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency, is an interim agreement under FSS Schedule 65 I B Drugs, Pharmaceuticals, & Hematology Related Products. The prime contractor is Genmab US Inc., a foreign-owned for-profit organization. The contract has a ceiling value of $25,000.00 and a period of performance through November 15, 2023. It was awarded on June 17, 2023 without any set-asides. The contract aims to...

This Federal Supply Schedule (FSS) contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency within the U.S. Department of Veterans Affairs. The contract, valued at a ceiling of $300,000.00, was awarded to Yaral Pharma Inc., a for-profit manufacturer, for a period of performance ending on April 30, 2028. The contract falls under Schedule 65 I B, "DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS", and is intended to provide the agency...

This Federal Supply Schedule (FSS) contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to Orchard Therapeutics North America, a for-profit foreign-owned company. The contract has a ceiling value of $225,000.00 and a period of performance from February 15, 2025 to February 14, 2030. The contract is for the procurement of drugs, pharmaceuticals, and hematology-related products under the FSS contract category 65 I B. The specific products and...